Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert

计划入组 129 人 · 首次发布于 2012 年 9 月 27 日

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

计划入组 12 人 · 首次发布于 2021 年 10 月 7 日

Pharmacokinetic Study of Vorolanib Tablets in Trial Participants With Hepatic Impairment

计划入组 36 人 · 首次发布于 2026 年 9 月 9 日

Vorolanib

C₂₃H₂₆FN₅O₃ · Rx

AAV gene therapy (intravitreal)

Injectable intravitreal depot formulation(DelSiTech)

DESERT ORTHOPEDIC CENTER

United States

Desert Minerals Ltd

United States

High Desert Respiratory

United States

EyePoint's DURAVYU Misses Primary Endpoint in Phase 3 LUGANO Trial for Wet AMD

DURAVYU Shows Promising Results in Phase 2 VERONA Trial for Retinal Diseases

Two Novel Therapies Show Promise for Neovascular AMD: Duravyu Insert and Ixo-vec Gene Therapy Demonstrate Safety and Efficacy in Phase 2 Trials